^
    BIOMARKER:
    NTRK2 fusion
    i
    Other names: NTRK2, TRKB, Neurotrophic tyrosine kinase, receptor, type 2
    Entrez ID:
    4915
    Related biomarkers:
    Expression
    Fusion
    Others
    NTRK2 fusion
    Solid Tumor
    entrectinib
    Sensitive
    :
    A1
    ESMO Open - 1wk
    NTRK2 fusion
    Sarcoma
    larotrectinib
    Sensitive
    :
    A1
    NTRK2 fusion
    Solid Tumor
    larotrectinib
    Sensitive
    :
    A1
    NTRK2 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Thyroid Gland Follicular Carcinoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Thyroid Gland Hurthle Cell Carcinoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Thyroid Gland Follicular Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Pancreatic Adenocarcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    GIST
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Breast Cancer
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Peritoneal Cancer
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Peritoneal Cancer
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Fallopian Tube Cancer
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Fallopian Tube Cancer
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Sarcoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Endometrial Cancer
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Thyroid Gland Papillary Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Small Intestinal Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Pancreatic Cancer
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Pancreatic Cancer
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    GIST
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    NSCLC
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Thyroid Gland Papillary Carcinoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Soft Tissue Sarcoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Gastroesophageal Junction Adenocarcinoma
    larotrectinib
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES